Guidant Prizm Defibrillator Launches Jan. 31; Fourth Quarter Sales Up 16%
This article was originally published in The Gray Sheet
Executive Summary
Shipments of Guidant's Ventak Prizm dual-chamber automatic implantable cardioverter defibrillator are anticipated to begin Jan. 31 following FDA approval via premarket approval application supplement, announced Jan. 24. A list price for the device is still being finalized.